Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy.
van den Boorn JG, Picavet DI, van Swieten PF, van Veen HA, Konijnenberg D, van Veelen PA, van Capel T, Jong EC, Reits EA, Drijfhout JW, Bos JD, Melief CJ, Luiten RM. van den Boorn JG, et al. Among authors: bos jd. J Invest Dermatol. 2011 Jun;131(6):1240-51. doi: 10.1038/jid.2011.16. Epub 2011 Feb 17. J Invest Dermatol. 2011. PMID: 21326294 Free article.
T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy.
Tjin EP, Konijnenberg D, Krebbers G, Mallo H, Drijfhout JW, Franken KL, van der Horst CM, Bos JD, Nieweg OE, Kroon BB, Haanen JB, Melief CJ, Vyth-Dreese FA, Luiten RM. Tjin EP, et al. Among authors: bos jd. Clin Cancer Res. 2011 Sep 1;17(17):5736-47. doi: 10.1158/1078-0432.CCR-11-0230. Epub 2011 Jul 12. Clin Cancer Res. 2011. PMID: 21750202
Skin immune system.
Bos JD, Luiten RM. Bos JD, et al. Cancer Treat Res. 2009;146:45-62. doi: 10.1007/978-0-387-78574-5_5. Cancer Treat Res. 2009. PMID: 19415192 Review. No abstract available.
A prospective, randomized, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on lesional and nonlesional skin.
de Groot M, Picavet DI, van Kuijk AW, Tak PP, Bos JD, de Rie MA, Teunissen MB. de Groot M, et al. Among authors: bos jd. Dermatology. 2012;225(4):298-303. doi: 10.1159/000343290. Epub 2012 Dec 21. Dermatology. 2012. PMID: 23257348 Free article. Clinical Trial.
Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells.
van der Aar AM, Picavet DI, Muller FJ, de Boer L, van Capel TM, Zaat SA, Bos JD, Janssen H, George TC, Kapsenberg ML, van Ham SM, Teunissen MB, de Jong EC. van der Aar AM, et al. Among authors: bos jd. J Invest Dermatol. 2013 May;133(5):1240-9. doi: 10.1038/jid.2012.500. Epub 2013 Feb 7. J Invest Dermatol. 2013. PMID: 23389393 Free article.
337 results